Radiopharm Theranostics Limited logo

RADXRadiopharm Theranostics Limited

RADX Stock Price, Valuation & Chart | Radiopharm Theranostics Limited

Compare

RADX Historical price chart

RADX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization2.78M
PE Ratio-0.36
EPS-5.94
Trading Volume11.01K
Today's High/Low2.3/2.09
Dividend Yield0.00
52 Week High/Low16.25/2.04
Shares Outstanding1.29M
RADX Financial Statement
RADX Analyst ratings
RADX Analysis & performance metrics

RADX Company profile

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical…

RADX Management team

Management
Phillip HainsCFO
Chief Financial Officer, Joint Company Secretary & Director
Nathan Jong C.A.
Joint Company Secretary
Dimitris Voliotis M.D.
Chief Medical Officer
Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD
Founder & Executive Chairman
Riccardo CanevariCEO
MD, Chief Executive Officer & Director
Hitesh Goel
Head of Project Management
Total 6 executives

RADX Frequently asked questions

What is Radiopharm Theranostics Limited (RADX) Stock Price?

Current stock price of Radiopharm Theranostics Limited (RADX) stock is $2.160. The stock price is -4.85% lower in the session. The intraday range can be seen from this page. Volume of Radiopharm Theranostics Limited (RADX) stock is 11.01K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Radiopharm Theranostics Limited (RADX) stock price going up or down today?

The stock price of Radiopharm Theranostics Limited (RADX) can change with earnings, company news, and overall market sentiment. Radiopharm Theranostics Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Radiopharm Theranostics Limited stock expensive at its current price?

Whether Radiopharm Theranostics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RADX on this page is -0.36. EPS on this page is -5.94. Compare those figures with peers and growth expectations before deciding if the current Radiopharm Theranostics Limited price is justified.

How has the stock price of Radiopharm Theranostics Limited (RADX) performed historically?

Historical performance for Radiopharm Theranostics Limited (RADX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RADX reacted to past earnings and market events.

Should I buy Radiopharm Theranostics Limited (RADX) stock, at this price?

Buying Radiopharm Theranostics Limited (RADX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.